AGP Picks
View all

Health Insider Virgin Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Insider Virgin Islands.

Press releases published on August 5, 2026

Aetna Tops Corporate Insight’s 2026 Health Plan Experience Benchmarks for Member Website and Mobile App
New Publications Highlight Challenges in Recognizing and Treating Anaphylaxis in Infants and Toddlers
Canadian Red Cross launches appeal to support communities impacted by wildfires in British Columbia
La Croix-Rouge canadienne lance un fonds de secours pour les communautés touchées par les feux de forêt en Colombie-Britannique
Stryker declares an $0.88 per share quarterly dividend
Acentra Health Acquires FEI Systems to Expand Technology and Clinical Solutions for Medicaid, Long-Term Services and Supports, Home- and Community-Based Services, and Behavioral Health
CORRECTION: Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026
PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system
Athelas Launches Practice Manager, the World's First Agentic Practice Management Suite
Pulmera Announces First Clinical Uses of CBeam™ 3D Imaging Platform
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
Teknova Launches Build-Tek™, a Proprietary AI Reagent Assistant That Allows Customers to Configure Complex Custom Product Requests in Minutes
How Families Can Stay Connected During Back-to-School Chaos
STERIS To Invest $600 Million to Build a Formulated Chemistries Manufacturing and Distribution Center of Excellence in North Carolina
IAOMT Supports HHS Directive to Phase Out Mercury Dental Fillings in Medicaid
BiomX Acquires 10% Stake in Motomea, Inventor of Advanced Electric Motor Technologies for Drone and Autonomous Systems
Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026
Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission
Acrivon Advances ACR-2316, a Potential First-in-Class WEE1/PKMYT1 Inhibitor, into Randomized Dose Expansion in its Ongoing Phase 1/2 Study
Propanc Biopharma Completes First Tranche of $5.0 Million Share Repurchase Program

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Insider Virgin Islands

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.